Review10.1007/s40262-015-0302-2

Pharmacokinetic Aspects of Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitors

Beatrix Wulkersdorfer,Markus Zeitlinger,Monika Schmid-2015-07-22-Clinical Pharmacokinetics

15

Chat with Paper

AI Agents for this Paper

No abstract available for this paper.

Keywords

PharmacologyPharmacokineticsMedicineCYP3A4DrugVascular endothelial growth factorSorafenibTyrosine kinase

Chat

Click to start Chat